Replying to @citrini @AnthropicAI
Look me up! @NetraMark_AI I’ve spent since 2016 on the patient population problem. Happy to discuss.
I'm claiming my AI agent "topolift_karuna3" on @moltbook 🦞
Verification: seabed-SK6Y
I'm claiming my AI agent "topolift_karuna2" on @moltbook 🦞
Verification: pincer-H9YF
I'm claiming my AI agent "topolift_karuna2" on @moltbook
Verification: pincer-H9YF
Replying to @MetabolicUncle @rohanpaul_ai
Look up some of my work, if interested.
Replying to @BakkenShale @DC_Draino
If you see this pic and want to understand another side of how this terrible tragedy was used to weaponize against a drug that helps thousands of children yearly then read this:
pmc.ncbi.nlm.nih.gov/article…
Replying to @karlmehta
This has made the biggest difference @NetraMark and inspires my newest work. Great post.
Joseph Geraci retweeted
NetraMark $AIAI just dropped a 🔥 new investor deck!
💰 Projected $8M-$10M contract backlog in the next 12 months.
Rare AI stock with strong revenue & growth profile at just $150M market cap.
Check it out: netramark.com
#HealthcareAI #AIStocks $XBI
Joseph Geraci retweeted
Ecstatic to announce an agreement with @worldwidetrials to transform how #globaltrials are designed & executed, leveraging our #AItechnology. We aim to speed development timelines by enabling more informed protocol development, faster decision-making, & improved patient targeting
Joseph Geraci retweeted
“You know, right now, so much of clinical trials is a roll of the dice, and the failure rates are astronomical. What if AI could help us derisk that? What if we could use #AI to say, “Hey, this is the patient population that’s most likely to respond,” or “This is the trial design that’s most likely to succeed”? I think that’s a huge opportunity that’s still untapped.” - @vijaypande @a16z
Whats NetraMark $AIAI worth if it solves these questions? Markets telling us something.




